FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test
The U.S. Food and Drug Administration approved the first liquid biopsy companion diagnostic that also uses next-generation sequencing (NGS) technology to identify patients with specific types of mutations of the …
Read More